Resveratrol inhibits polyphosphoinositide metabolism in activated platelets

Biochimica et Biophysica Acta - Biomembranes

Volumn 1714, Issue 2, 2005, Pages 125-133

  Olas, Beata ^a   Wachowicz, Barbara ^a   Holmsen, Holm ^b   Fukami, Miriam H ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Blood platelet; Polyphosphoinositide signalling; Resveratrol

Indexed keywords

CYTIDINE DIPHOSPHATE DIACYLGLYCEROL INOSITOL 3 PHOSPHATIDYLTRANSFERASE; LYSOSOME ENZYME; PHOSPHATIDIC ACID; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; RESVERATROL;

ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG INHIBITION; ENZYME INHIBITION; HUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEADY STATE; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

BLOOD PLATELETS; CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE; CELLS, CULTURED; DOWN-REGULATION; HUMANS; MEMBRANE PROTEINS; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; STILBENES; THROMBIN; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 23644461400     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2005.06.008     Document Type: Article

References (43)

1. S. Rotondo, D. Rotilio, C.H. Cerletti, and G. De Gaetano Red wine, aspirin and platelet function Thromb. Haemost. 76 1996 813 821
2. O. Daniel, M.S. Meier, J. Schlatter, and P. Frischknecht Selected phenolic compounds in cultivated plants: ecologic functions, health implications, and modulation by pesticides Environ. Health Perspect. 107 1999 109 114
3. L. Fremont Biological effects of resveratrol Life Sci. 66 2000 663 673
4. E. Middleton, C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer Pharmacol. Res. 52 2000 673 751
5. S. Pervaiz Resveratrol: from grapevines to mammalian biology FASEB J. 17 2003 1975 1985
6. T.M.A. ElAttar, A.S. Virji, Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anti-Cancer Drugs 10, 187-193.
7. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Monn, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 219
8. E. Ulsperger, G. Hamilton, M. Raderer, G. Baumgartner, M. Hejna, O. Hoffman, and R. Mallinger Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants Int. J. Oncol. 15 1999 955 999
9. D. Blache, L. Gesquiere, N. Loreau, and P. Durand Oxidant stress: the role of nutrients in cell-lipoprotein interactions Proc. Nutr. Soc. 58 1999 559 563
10. L. Fremont, L. Belguendouz, and S. Delpal Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids Life Sci. 64 1999 2511 2521
11. J.L. Johnson, and K.R. Maddipati Paradoxical effects of resveratrol on the two prostaglandin H synthases Prostaglandins Other Lipid Mediators 56 1998 131 143
12. J. Martinez, and J.J. Moreno Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production Biochem. Pharmacol. 59 2000 865 870
13. A.A. Bertelli, L. Giovannini, D.Z. Giannessi, M. Migliori, W. Bernini, M. Fregoni, and A. Bertelli Antiplatelet activity of synthetic and natural resveratrol in red wine Int. J. Tissue React. 17 1995 1 3
14. A.A. Bertelli, L. Giovannini, W. Bernini, M. Migliori, M. Fregoni, L. Baveresco, and A. Bertelli Antiplatelet activity of cis-resveratrol Drugs Exp. Clin. Res. 22 1996 61 63
15. B. Olas, H.M. Żbikowska, B. Wachowicz, T. Krajewski, A. Buczyñski, and A. Magnuszewska Inhibitory effect of resveratrol on free radical generation in blood platelets Acta Biochim. Pol. 46 1999 991 996
16. H.M. Żbikowska, B. Olas, B. Wachowicz, and T. Krajewski Response of blood platelets to resveratrol Platelets 10 1999 251 256
17. H.M. Żbikowska, and B. Olas Antioxidants with carcinostatic activity (resveratrol, vitamin E and selenium) in modulation of blood platelet adhesion J. Physiol. Pharmacol. 3 2000 513 520
18. B. Olas, B. Wachowicz, J. Saluk-Juszczak, T. Zieliñski, W. Kaca, and A. Buczyñski Antioxidant activity of resveratrol in endotoxin-stimulated blood platelets Cell Biol. Toxicol. 17 2001 10 19
19. B. Olas, B. Wachowicz, J. Saluk-Juszczak, J. Szewczuk, and W. Kaca The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin Microbios 105 2001 7 13
20. B. Olas, B. Wachowicz, J. Saluk-Juszczak, and T. Zieliñski Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin Thromb. Res. 107 2002 141 145
21. B. Olas, B. Wachowicz, A. Stochmal, and W. Oleszek Inhibition of oxidative stress in blood platelets by different phenolics from Yucca schidigera Roezl. Bark Nutrition 19 2003 633 640
22. B. Lages, M.C. Scrutton, and H. Holmsen Studies on gel-filtered human platelets: isolation and characterization in a medium containing no added Ca2+, Mg2+, or K+ J. Lab. Clin. Med. 85 1975 811 825
23. O.B. Tysnes, G.M. Aarbakke, A.J. Verhoeven, and H. Holmsen Thin-layer chromatography of polyphosphoinositides from platelet extracts: interference by an unknown phospholipid Thromb. Res. 40 1985 329 338
24. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
25. K.R. Auger, L.A. Serunian, S.P. Soltoff, P. Libby, and L.C. Cantley PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells Cell 57 1989 167 175
26. V.M. Steen, and H. Holmsen Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion Thromb. Haemost. 54 1985 680 683
27. C.A. Dangelmaier, and H. Holmsen Determination of acid hydrolases in human platelets Anal. Biochem. 104 1980 182 191
28. B. Olas, K. Lundell, H. Holmsen, and M.H. Fukami Biochemical properties of platelet microparticle membranes formed during exocytosis resemble organelles more than plasma membrane FEBS Lett. 525 2002 29 32
29. A. Ryningen, and H. Holmsen Thrombin per se does not induce tyrosine phosphorylation in human platelets as judged by Western blotting, while collagen does: the significance of autocrine stimulation Biochem. Biophys. Res. Commun. 245 1998 757 763
30. A.J.M. Verhoeven, O.B. Tysnes, O. Horvli, C.A. Cook, and H. Holmsen Stimulation of phosphate uptake in human platelets by thrombin and collagen J. Biol. Chem. 262 1987 7047 7052
31. Y. Ozaki, Y. Matsumoto, Y. Yatomi, M. Higashira, T. Kariya, and K. Shoji Effects of five anion blockers on thrombin and ionomycin-activated platelet function Biochem. Pharmacol. 38 1987 2147 2152
32. E.J. Calabrese, and L.A. Baldwin Toxicology rethinks its central belief Nature 421 2003 691 692
33. P. Tharmapathy, M.H. Fukami, and H. Holmsen The stimulatory, inhibitory and permeabilizing effects of cationic amphiphilic drugs on thrombin-stimulated human platelets Biochem. Pharmacol. 60 2000 1267 1277
34. K.A. Hinchliffe, R.F. Irvine, and N. Divecha Regulation of PtdIns4P 5-kinase C by thrombin-stimulated changes in its phosphorylation state in human platelets Biochem. J. 329 1998 115 119
35. H.L. Yin, and P.A. Janmey Phosphoinositide regulation of the actin cytoskeleton Annu. Rev. Physiol. 65 2003 761 789
36. K.-O. Jonsson, H.L.M. Hedin, and C.J. Fowler Investigation into the rapid effects of 17β-estradiol and neuroactive steroids upon β-amyloid (25-35)-induced activation of phosphoinositide-specific phospholipase C in human platelets Methods Find. Exp. Clin. Pharmacol. 22 2000 615 620
37. J. Tou, and C. Urbizo Resveratrol inhibits the formation of phosphatidic acid and diglyceride in chemotactic peptide- or phorbol ester-stimulated human neutrophils Cell. Signalling 13 2001 191 197
38. R. Bucki, J.J. Pastore, F. Giraud, J.-C. Sulpice, and P.A. Janmey Flavonoid inhibition of platelet procoagulant activity and phosphoinositide synthesis J. Thrombos. Haemostas. 1 2003 1820 1828
39. J. Zheng, and V.D. Ramirez Inhibition of mitochondrial proton FoF1 ATPase/ATP synthase by polyphenolic phytochemicals Br. J. Pharmacol. 130 2000 1115 1123
40. J.W.N. Akkerman, G. Gorter, L. Schrama, and H. Holmsen A novel technique for rapid determination of energy consumption in platelets Biochem. J. 210 1983 145 155
41. S.J. Slater, J.L. Seiz, A.C. Cook, B.A. Stagliano, and C.J. Buzas Inhibition of protein kinase C by resveratrol Biochim. Biophys. Acta 1637 2003 59 69
42. T. Rygh, and H. Holmsen Chlorpromazine makes the platelet plasma membrane specifically permeable for low-molecular substances and reduces ATP production Biochem. Pharmacol. 40 1990 373 376
43. M.A. Carluccio, L. Siculella, M.A. Ancora, M. Massaro, E. Scoditti, C. Storelli, P. Visioli, A. Distante, and R. De Caterina Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals Arterioscler. Thromb. Vasc. Biol. 23 2003 622 669